Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease

Journal of Clinical Investigation

Volumn 111, Issue 6, 2003, Pages 907-913

  Lennon, Vanda A ^a,b   Ermilov, Leonid G ^b   Szurszewski, Joseph H ^b   Vernino, Sreven ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; RECOMBINANT RECEPTOR;

ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTONOMIC NEUROPATHY; BLADDER DISTENSION; CELL VIABILITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEMENTIA; EPILEPSY; FEMALE; GASTROINTESTINAL HYPOMOTILITY; GASTROINTESTINAL MOTILITY; GENE MUTATION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; LUNG SMALL CELL CANCER; MOTOR DYSFUNCTION; MYDRIASIS; NERVE CELL; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARANEOPLASTIC AUTOIMMUNE AUTONOMIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SEIZURE; SMALL CELL CARCINOMA; SYMPATHETIC GANGLION; ANIMAL; AUTONOMIC GANGLION; BLADDER DISEASE; BLOOD; CELL CULTURE; CLASSIFICATION; EYE DISEASE; IMMUNOLOGY; LUNG TUMOR; PATHOPHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; CARCINOMA, SMALL CELL; EYE DISEASES; FEMALE; GANGLIA, AUTONOMIC; HUMANS; IMMUNIZATION; LUNG NEOPLASMS; RABBITS; RECEPTORS, NICOTINIC; TUMOR CELLS, CULTURED; URINARY BLADDER DISEASES;

EID: 85047688696     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17429     Document Type: Article

References (36)

1. Musunuru, K., and Darnell, R.B. 2001. Review. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu. Rev. Neurosci. 24:239-262.
2. Steinman, L., Martin, R., Bernard, C., Conlon, P., and Oksenberg, J.R. 2002. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25:491-505.
3. Willison, H., Stoll, G., Toyka, K.V., Berger, T., and Hartung, H.P. 2002. Autoimmunity and inflammation in the peripheral nervous system. Research update. Trends Neurosci. 25:127-129.
4. Patrick, J., and Lindstrom, J. 1973. Autoimmune response to acetylcholine receptor. Science. 180:871-872.
5. Lennon, V.A., Lindstrom, J.M., and Seybold, M.E. 1975. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 141:1365-1375.
6. Drachman, D.B. 1994. Myasthenia gravis. N. Engl. J. Med. 330:1797-1810.
7. Picciotto, M.R., et al. 2001. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol. Ther. 9:2:89-108.
8. Li, M., and Lester, H.A. 2001. Ion channel diseases of the central nervous system. CNS Drug Rev. 7:214-240.
9. Lukas, R.J., et al. 1999. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51:397-401.
10. Vernino, S., et al. 2000. Autoantibodies To ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343:847-855.
11. Nelson, M.E., et al. 2001. Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells. J. Gen. Physiol. 118:563-582.
12. Schoepfer, R., Halvorsen, S.W., Conroy, W.G., Whiting, P., and Lindstrom, J. 1989. Antisera against an acetylcholine receptor α3 fusion protein bind to ganglionic but not to brain nicotinic acetylcholine receptors. FEBS Lett. 257:393-399.
13. Buisson, B., Vallejo, Y.F., Green, W.N., and Bertrand, D. 2000. The unusual nature of epibatidine responses at the α4β2 nicotinic acetylcholine receptor. Neuropharmacology. 39:2561-2569.
14. 7) types coexpressed in a small cell lung carcinoma. J. Neurocbem. 69:2302-2311.
15. Vernino, S., Adamski, J., Kryzer, T.J., Fealey, R.D., and Lennon, V.A. 1998. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 50:1806-1813.
16. Bruns, R., Lawson-Wendling, K., and Pugsley, T. 1983. A rapid filtration assay for soluble receptors using polyethyleneimine-treated filters. Anal. Biochem. 132:74-81.
17. Vernino, S., Kryzet, T.J., and Lennon, V.A. 2002. Autoimmune autonomic neuropathy and neuromusculat hyperexcitability disorders. In Manual ofclinical and laboratory immunology. 6th edition. N.R. Rose, R.G. Hamilton, and B. Detrick, editors. ASM Press. Washington, DC, USA. 1013-1017.
18. Ermilov, L.G., et al. 1995. Simultaneous 3-D detection of nicotinic acetylcholine receptor clusters and VIP-ergic synaptic boutons in guinea pig peripheral autonomic ganglia. Gastroenterology. 108:A963. (Abstr.).
19. Szurszewski, J.H., and Miller, S.M. 1994. Physiology of prevertebral ganglia. In Physiology of gastrointestinal tract. 3rd edition. L.R. Johnson, editor. Raven Press. New York, New York, USA. 795-877.
20. Fukunaga, H., Engel, A.G., Lang, B., Newsom-Davis, J., and Vincent, A. 1983. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl. Acad. Sci. U. S. A. 80:7636-7640.
21. Xu, W., et al. 1999. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 96:5746-5751.
22. 4 subunits ofneuronal nicotinic acetylcholine receptors. J. Neurosci. 19:9298-9305.
23. 3 nicotinic acetylcholine receptor subunit. Gastroenterology. 121:350-357.
24. Goldstein, D.S., et al. 2002. Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin. Auton. Res. 12:281-285.
25. Zaimis, E. 1965. The immunosympathectomized animal: a valuable tool in physiological and pharmacological research. J. Physiol. 177:35P-36P.
26. Brimijoin, S., and Lennon, V.A. 1990. Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc. Natl. Acad. Sci. U. S. A. 87:9630-9634.
27. Brimijoin, S., Moser, V., Hammond, P., Oka, N., and Lennon, V.A. 1993. Death of intermedio-lateral spinal cord neurons follows selective, complement-mediated destruction of peripheral preganglionic sympathetic terminals by acetylcholinesterase antibodies. Neuroscience. 54:201-223.
28. Lennon, V.A., et al. 1995. Calcium-channel antibodies in Lambert-Eaton myasthenic syndrome and other paraneoplastic syndromes. N Engl. J. Med. 332:1467-1474.
29. 45Ca flux in human small cell carcinoma line. Nature. 317:737-739.
30. Yu, Z., et al. 2001. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann. Neurol. 49:146-154.
31. Griesmann, G.E., Harper, C.M., and Lennon, V.A. 1998. Paraneoplastic myasthenia gravis and lung carcinoma: distinction from Lambert-Eaton syndrome and hypothesis of aberrant muscle acetylcholine receptor (AChR) expression. Muscle Nerve. 7(Suppl.):S122.
32. Maneckjee, R., and Minna, J.D. 1990. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. U. S. A. 87:3294-3298.
33. 5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. Proc. Natl. Acad. Sci. U. S. A. 89:1572-1576.
34. Codignola, A., et al. 1994. Serotonin release and cell proliferation are under the control of α-bungarotoxin-sensitive nicotinic receptors in small-cell lung carcinoma cell lines. FEBS Lett. 342:286-290.
35. Quik, M., Chan, J., and Patrick, J. 1994. Alpha-bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res. 655:161-167.
36. Klein, C.M., et al. 2003. The spectrum of autoimmune autonomic neuropathies. Ann. Neurol. In press.